Chanel loses European court fight in trademark dispute with Huawei

French luxury house Chanel on Wednesday lost its trademark fight with Huawei Technologies after a top European court said their logos bear no similarity to each other. As Reuters reports, the trademark spat underlines how luxury brands jealously guard their signature logos and trademarks that often symbolise luxury, style and exclusivity to millions of people worldwide.

The dispute dated to 2017 when Huawei sought approval from the EU Intellectual Property Office (EUIPO), a trademark body, to register its computer hardware trademark which has two vertical interlocking semi-circles. Privately owned Chanel objected, saying that the design was similar to its registered French logo of two horizontal interlocking semi-circles used for its perfumes, cosmetics, costume jewellery, leather goods, and clothing.

In 2019, the trademark office dismissed Chanel's objection, saying there was no similarity and no likelihood of confusion in the mind of the public. The French luxury house subsequently challenged the ruling at the Luxembourg-based General Court, which dismissed the appeal in its ruling on Wednesday.

"The figurative marks at issue are not similar. The marks must be compared as applied for and registered, without altering their orientation," the tribunal of judges said.

The tribunal said the visual differences in the two logos were significant.

"In particular, Chanel's marks have more rounded curves, thicker lines and a horizontal orientation, whereas the orientation of the Huawei mark is vertical. Consequently, the General Court concludes that the marks are different," it said.

The ruling can be appealed to the EU Court of Justice, Europe's highest.

Similar articles

  • Covid-19 vaccine makers slump on expected patent waiver

    Covid-19 vaccine makers slump on expected patent waiver

    The stocks of all companies involved in production of Covid-19 vaccines fell, as US and EU backed the call from the World Health Organisation to waive patent rights claims over the jabs production, Reuters reported. The share slumps came even as some analysts raised doubts about any near-term pressure on Covid-19 vaccine sales from discussions of waiving intellectual property rights, given the manufacturing complexity and scarcity of raw materials. Combined, Pfizer and Moderna have forecast a total of over $45 billion in sales this year for their Covid-19 vaccines.

    39
  • Tesla misses key technology target

    Tesla misses key technology target

    The producer of electric cars Tesla admitted it would miss a target set by its majority owner Elon Musk - to develop full self-driving vehicles by the end of 2021, Reuters reported. The announcement seriously undermines Tesla ambitions to influence the global EV market. Documents released in media earlier this week showed that the company is falling behind announced deadlines while incidents with EVs continue to rise.

    28
  • Bayer loses court fight over EU pesticides

    Bayer loses court fight over EU pesticides

    The German chemical conglomerate Bayer lost an appeal in EU court against a ban related to the usage of pesticides amid growing concerns linked to the extinction on bees, Reuters reported. The European Union's top court upheld the EU's partial ban on insecticides linked to harming bees, preventing their use on certain crops. Bayer appealed to overturn a lower EU court's 2018 decision to uphold the EU ban.

    61